In our study, we found that TRIM31 directly interacted with p53 and subsequently stabilized and activated p53 by inducing K63-linked ubiquitination as well as inhibiting MDM2-mediated K48-linked ubiquitination of p53 and then suppressing breast cancer progression (22). The gene discussed is TP53; the disease is breast cancer.